Award
NIH Reporter #1R01CA309039-01
Genome-Wide In Vivo CRISPR Screens in Human T Cells Identify GPCR Pathway Targets to Enhance CAR-T Therapies for Solid Tumors
Recipient
National Cancer Institute (NCI), part of NIH
Award Amount
$680,597.00
Ceiling
$680,597.00
Awarded
March 25, 2026
Identifier
1R01CA309039-01
NIH awarded a research grant to study genome-wide CRISPR screens in human T cells to find GPCR pathway targets to improve CAR-T therapies for solid tumors.
Description
A research grant opportunity from NIH for a project involving genome-wide CRISPR screens in human T cells to identify GPCR pathway targets for enhancing CAR-T therapies for solid tumors. The project is funded by the National Cancer Institute.